Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Seattle Biotech -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (5)	3/9/2000 7:06:00 AM
From: Mike McFarland	Respond to of 70

Headlines... Corixa plans to sell 2.25 million shares in a follow-on offering--should raise about 100M Dendreon is looking to raise 100M in an initial public offering. The Seattle Times reported that J&J has been selling its interest in CTIC, and is down to one percent. NeoRx reports cancer treatment effective in mice, stock went wild running from the lower $20s on Friday March 3rd..into the $60s on Monday March 6th, then fading back to the $30s. This was a few bucks a share a few months ago, and now has a marketcap of around 700M.